{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-052150","form_type":"8-K","ticker":"CAMP","cik":"0001736730","company_name":"Camp4 Therapeutics Corp","filed_at":"2026-08-04T11:10:14+00:00","discovered_at":"2026-08-04T11:15:02.363187+00:00","generated_at":"2026-08-04T11:15:22.436305+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"CAMP4 Therapeutics closes second tranche of $100M private placement, raising $50.1M","bullets":["Second closing gross proceeds $50.1M from 10.76M shares at $1.53 and 21.93M pre-funded warrants at $1.5299.","Total private placement $100M; proceeds to fund CMP-002 Phase 1/2 trial for SYNGAP1-related disorder.","Investors include Coastlands Capital, Janus Henderson, Balyasny, Vivo Capital, 5AM Ventures, Adage Capital, Trails Edge, CURE SYNGAP1.","Pre-funded warrants exercisable at $0.0001, subject to 19.99% beneficial ownership limitation.","Securities issued in private placement not registered under Securities Act."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-052150","json":"https://secwatch.observer/filing/0001628280-26-052150.json","markdown":"https://secwatch.observer/filing/0001628280-26-052150.md","text":"https://secwatch.observer/filing/0001628280-26-052150.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1736730/000162828026052150/0001628280-26-052150-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1736730/000162828026052150/camp-20260803.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-04T11:15:22.436305+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}